Long-term quality of life in cervical dystonia after treatment with abobotulinum toxin A: a 2-year prospective study. (Q55100812)

20 June 2018

title

Long-term quality of life in cervical dystonia after treatment with abobotulinum toxin A: a 2-year prospective study. (English)

1 reference

20 June 2018

1 reference

1 reference

2

Narong Maneeton

1 reference

20 June 2018

Subsai Kongsaengdao

series ordinal

1

object named as

Subsai Kongsaengdao

1 reference

20 June 2018

author name string

Benchalak Maneeton

series ordinal

3

1 reference

20 June 2018

language of work or name

English

0 references

publication date

26 April 2018

1 reference

20 June 2018

Neuropsychiatric Disease and Treatment

published in

1 reference

20 June 2018

volume

14

1 reference

20 June 2018

page(s)

1119-1124

1 reference

20 June 2018

Creative Commons Attribution-NonCommercial 3.0 Unported

copyright license

start time

1 April 2018

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Quality of life in cervical dystonia after treatment with botulinum toxin A: a 24-week prospective study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5927345

Impact of Neu-botulinumtoxinA on the Severity and Quality of Life of Cervical Dystonia Patients

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5927345

Factors affecting the health-related quality of life of patients with cervical dystonia and impact of treatment with abobotulinumtoxinA (Dysport): results from a randomised, double-blind, placebo-controlled study.

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5927345

An open-label cohort study of the improvement of quality of life and pain in de novo cervical dystonia patients after injections with 500 U botulinum toxin A (Dysport)

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5927345

EFNS guidelines on diagnosis and treatment of primary dystonias

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5927345

Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5927345

The management of cervical dystonia

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5927345

A systematic review on the diagnosis and treatment of primary (idiopathic) dystonia and dystonia plus syndromes: report of an EFNS/MDS-ES Task Force

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5927345

Treatment of cervical dystonia with botulinum toxins

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5927345

Botulinum toxin type A versus anticholinergics for cervical dystonia

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5927345

Case-finding for depression in elderly people: balancing ease of administration with validity in varied treatment settings

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5927345

Botulinum toxin therapy for cervical dystonia.

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5927345

Classification and genetics of dystonia

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5927345

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5927345

The botulinum toxins in the treatment of cervical dystonia

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5927345

A prevalence study of primary dystonia in eight European countries

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5927345

Idiopathic cervical dystonia: clinical characteristics

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5927345

Quality of life in patients with focal dystonia

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5927345

Determinants and status of quality of life after long-term botulinum toxin therapy for cervical dystonia

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5927345

Factors affecting the health-related quality of life of patients with cervical dystonia and the impact of botulinum toxin type A injections.

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5927345

CDIP-58 can measure the impact of botulinum toxin treatment in cervical dystonia.

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5927345

Long-term effect of botulinum toxin on impairment and functional health in cervical dystonia.

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5927345

Botulinum A toxin treatment in spasmodic torticollis: report of 56 patients

13 August 2018

1 reference

12 December 2020

The Children's Depression Inventory as a screen for depression in Thai children

1 reference

12 December 2020

Psychiatric comorbidity in patients with spasmodic torticollis

1 reference

12 December 2020

1 reference

12 December 2020

Decreased neck muscle strength is highly associated with pain in cervical dystonia patients treated with botulinum toxin injections11No commercial party having a direct financial interest in the results of the research supporting this article has or

1 reference

12 December 2020

Treatment of dystonia

1 reference

12 December 2020

Treatment of complex cervical dystonia with botulinum toxin: Involvement of deep-cervical muscles may contribute to suboptimal responses

1 reference

12 December 2020

Identifiers

DOI

10.2147/NDT.S152252

1 reference

20 June 2018

PMC publication ID

5927345

1 reference

20 June 2018

PubMed publication ID

29731634

1 reference

20 June 2018